US Archives - Page 66 of 112 - European Medical Journal

Can Metformin Reduce Non-Melanoma Skin Cancer?

A recent study has highlighted metformin’s potential role in reducing the risk of non-melanoma skin cancers (NMSC), offering intriguing possibilities for dermatological and oncological care.

Nail Psoriasis: Manifestations, Diagnosis, and Management

Psoriasis is a common, chronic inflammatory dermatosis, and patients with psoriasis often develop nail involvement. It is estimated that…

AI Boosts Breast Cancer Detection in Real-World Study

A recent observational study has shown that AI can significantly enhance breast cancer detection rates in mammography screening without increasing unnecessary recalls.

Shorter TB Treatment Protocols Approved

New clinical practice guidelines for tuberculosis (TB) treatment have been released, reflecting recent clinical trial data.

Traumatic Brain Injuries Trends Explored

In 2021, traumatic brain injuries (TBIs) claimed 69,473 lives across the United States, with significant disparities in mortality rates tied to age, race, and geographic location.

Cardiovascular Risk Soars in Cutaneous Lupus Erythematosus

A new study reveals that patients with cutaneous lupus erythematosus (CLE) face significantly higher risks of atherosclerotic cardiovascular disease (ASCVD) compared to the general population.

Intravaginal Cooling Relief for Vaginal Candidiasis

Vulvovaginal candidiasis (VVC), a common condition caused by Candida albicans, affects millions of women annually and often resists standard antifungal treatments.

Shared Oncology Care In A Post-HCT Breakthrough

Post-transplant care has demonstrated that collaboration between hematopoietic cell transplantation (HCT) specialists and local oncologists can safely enhance patient outcomes while reducing caregiver burdens in a recently published research article.

L.A. Wildfires Worsen Respiratory Risks

Los Angeles healthcare professionals face a growing crisis as wildfire smoke engulfs the region, posing severe health risks for millions.

Doxycycline Postexposure Prophylaxis Shows Major Impact in STI Prevention

A new cohort study reveals that doxycycline postexposure prophylaxis (DoxyPEP) significantly reduces rates of bacterial sexually transmitted infections (STIs) among individuals using HIV preexposure prophylaxis (PrEP).